Teva (TEVA) to acquire Cephalon (CEPH) for $81.50/share; deal valued at $6.8 billion
Tweet Send to a Friend
Teva (Nasdaq: TEVA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
